Suppr超能文献

在2019冠状病毒病大流行期间转向远程医疗进行癌症遗传咨询和检测的影响。

The impact of converting to telehealth for cancer genetic counseling and testing during the COVID-19 pandemic.

作者信息

Proussaloglou Ellie M, Koelliker Ekaterina L, Laprise Jessica, Wilbur Jennifer Scalia, Robison Katina, Stuckey Ashley, Crawford Katherine

机构信息

Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Providence, Rhode Island, USA.

The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.

出版信息

J Genet Couns. 2024 Aug;33(4):834-841. doi: 10.1002/jgc4.1792. Epub 2023 Sep 22.

Abstract

The COVID-19 outbreak in March 2020 resulted in a shift to telemedicine for cancer genetic counseling (GC). The objective of this study was to determine the effect of telehealth (TH) services on patient acceptance of recommended genetic testing, time to test completion, and follow-up test-disclosure GC appointment, as well as compliance with National Comprehensive Cancer Network (NCCN) recommendations for medical screenings when testing positive for a genetic variant. Data for this retrospective cohort study were collected at a tertiary-care academic health center using the electronic medical record and laboratory portal. Patients with traditional in-person visits (the 2019 control group) and date-matched TH visits (2020) were compared. In total, 206 new GC appointments occurred in the in-person group and 184 new appointments occurred in the TH group. The in-person group was more likely to consent to testing than the TH cohort (92.6% vs. 82.1%, p = 0.003) and had increased rates of sample submission (99.5% vs. 93.75%, p < 0.01), as well as a shorter turn-around time between their initial appointment and laboratory result reporting (34.24 vs. 20.32 days, p < 0.01). There was no increase in time from initial to follow-up GC appointments (67.87 days for control, 62.39 days for THs, p = 0.37). With >2.5 years of follow-up for all study participants, there were no statistically significant differences in pathogenic variant (PV) carrier compliance with screening recommendations. During the COVID-19 pandemic, use of TH allowed patients to access GC with no significant differences in time between initial consultation and follow-up. However, in-person visits were associated with increased patient willingness to consent to and complete genetic testing. This work offers a nuanced look at the success of TH GC during the pandemic and follow-up with screening recommendations, while offering future opportunities to address the acceptance of testing as GC is practiced in a virtual or hybrid model.

摘要

2020年3月爆发的新型冠状病毒肺炎疫情导致癌症遗传咨询(GC)转向远程医疗。本研究的目的是确定远程医疗(TH)服务对患者接受推荐基因检测的情况、检测完成时间、后续检测结果披露遗传咨询预约的影响,以及基因变异检测呈阳性时遵守美国国立综合癌症网络(NCCN)医学筛查建议的情况。这项回顾性队列研究的数据是在一家三级医疗学术健康中心通过电子病历和实验室门户网站收集的。对进行传统面对面就诊的患者(2019年对照组)和日期匹配的远程医疗就诊患者(2020年)进行了比较。面对面就诊组共进行了206次新的遗传咨询预约,远程医疗组进行了184次新预约。面对面就诊组比远程医疗队列更有可能同意进行检测(92.6%对82.1%,p = 0.003),样本提交率更高(99.5%对93.75%,p < 0.01),并且从初次预约到实验室结果报告的周转时间更短(34.24天对20.32天,p < 0.01)。从初次到后续遗传咨询预约的时间没有增加(对照组为67.87天,远程医疗组为62.39天,p = 0.37)。对所有研究参与者进行了超过2.5年的随访,致病性变异(PV)携带者在遵守筛查建议方面没有统计学上的显著差异。在新型冠状病毒肺炎大流行期间,使用远程医疗使患者能够获得遗传咨询,初次咨询和随访之间的时间没有显著差异。然而,面对面就诊与患者同意并完成基因检测的意愿增加有关。这项工作对大流行期间远程医疗遗传咨询的成功以及遵循筛查建议进行了细致入微的观察,同时为解决在虚拟或混合模式下进行遗传咨询时检测的接受度问题提供了未来的机会。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验